Multicentre Observational Study on Community Acquired Intraabdominal Infections Management

Intraabdominal Infections Clinical Trial

— PERICOM  

Official title:

Multicentre Observational Study on Community Acquired Intraabdominal Infections Management: the PERICOM Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03544203
• Other study ID #: 2017-A03407-46
• Status: Completed
• Start date: April 1, 2018
• Est. completion date: March 30, 2019

Study information

• Verified date: January 2019
• Source: Centre Hospitalier Universitaire de Nimes
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Intraabdominal infection require rapid care management including antibiotic therapy and source control. Morbidity and mortality associated with Intraabdominal infections remain high. French recommendations have been edited in 2000 further updated in 2014. Delay in diagnosis and surgery can lead to worsened outcomes. However, little data are available on early community-acquired intraabdominal infections management to identify risk factors of inadequate management.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: March 30, 2019
• Est. primary completion date: February 28, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• = 18 years

• patients admitted to emergency department for a diagnosis of proven or suspected intraabdominal infection requiring surgery

Exclusion Criteria:

• primary intraabdominal infection

• health-care associated intraabdominal infection

• abdominal trauma

• patient under guardianship

• opt out consent

• patient already enrolled in the present study

Related Conditions & MeSH terms

• Communicable Diseases
• Infection
• Intraabdominal Infections

Locations

Country	Name	City	State
France	CHU d'Amiens	Amiens
France	CHU Angers	Angers
France	Hia Percy	Clamart
France	CHU Clermont-Ferrand	Clermont-Ferrand
France	Hôpital Henri Mondor	Créteil
France	CHU Grenoble La Tronche	Grenoble
France	CHRU Lille	Lille
France	Lyon-Sud Pierre Bénite	Lyon
France	AP HM La Timone	Marseille
France	Ap Hm La Timone	Marseille
France	CHU Nimes	Nîmes
France	CHU Bichat Claude Bernard	Paris
France	Le Kremlin-Bicêtre	Paris
France	CHU Strasbourg	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	length of stay		6 month